Total Payments
$1,863
2024 Payments
$16.29
Companies
22
Transactions
101
Medicare Patients
1,826
Medicare Billing
$272,215
Payment Breakdown by Category
Food & Beverage$1,343 (72.1%)
Education$437.25 (23.5%)
Other$82.76 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,343 | 92 | 72.1% |
| Education | $437.25 | 5 | 23.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $82.76 | 4 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $526.83 | 10 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $212.32 | 24 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $157.31 | 8 | $0 (2024) |
| Biogen, Inc. | $133.33 | 7 | $0 (2021) |
| Allergan Inc. | $121.45 | 16 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $101.22 | 5 | $0 (2020) |
| Lundbeck LLC | $83.46 | 4 | $0 (2018) |
| Acorda Therapeutics, Inc | $82.76 | 4 | $0 (2019) |
| GENZYME CORPORATION | $58.34 | 3 | $0 (2019) |
| Lilly USA, LLC | $53.08 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.29 | 1 | Novartis Pharmaceuticals Corporation ($16.29) |
| 2023 | $67.64 | 4 | Amneal Pharmaceuticals LLC ($44.03) |
| 2021 | $147.21 | 3 | Teva Pharmaceuticals USA, Inc. ($111.45) |
| 2020 | $144.85 | 8 | Supernus Pharmaceuticals, Inc. ($38.34) |
| 2019 | $609.67 | 38 | Supernus Pharmaceuticals, Inc. ($134.23) |
| 2018 | $426.20 | 19 | Teva Pharmaceuticals USA, Inc. ($159.69) |
| 2017 | $450.84 | 28 | Teva Pharmaceuticals USA, Inc. ($137.99) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Neurology | ||||||
| 10/31/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: NEUROLOGY | ||||||
| 09/06/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/22/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROLOGY | ||||||
| 07/25/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEUROLOGY | ||||||
| 09/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PRIMARY CARE | ||||||
| 07/14/2021 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.45 | General |
| 06/30/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: AED | ||||||
| 11/27/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.52 | General |
| Category: AED | ||||||
| 10/22/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: PD | ||||||
| 06/26/2020 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.89 | General |
| Category: Neuroscience | ||||||
| 02/25/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Immunology | ||||||
| 02/18/2020 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROLOGY | ||||||
| 01/28/2020 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.05 | General |
| Category: AED | ||||||
| 12/30/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: AED | ||||||
| 12/13/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $9.90 | General |
| Category: AED | ||||||
| 12/06/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $9.32 | General |
| Category: AED | ||||||
| 12/03/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $8.23 | General |
| Category: AED | ||||||
| 11/26/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/19/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.26 | General |
| 11/05/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Central Nervous System | ||||||
| 10/15/2019 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 10/10/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $7.15 | General |
| Category: AED | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 463 | 630 | $202,650 | $71,525 |
| 2022 | 5 | 427 | 539 | $151,010 | $62,612 |
| 2021 | 8 | 484 | 655 | $146,150 | $75,582 |
| 2020 | 4 | 452 | 624 | $144,180 | $62,496 |
Total Patients
1,826
Total Services
2,448
Medicare Billing
$272,215
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 399 | $109,725 | $35,858 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 161 | 161 | $68,425 | $26,102 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 70 | $24,500 | $9,565 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 320 | $76,320 | $28,986 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 138 | 138 | $53,400 | $23,488 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 47 | $14,350 | $6,851 | 47.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,080 | $1,981 | 48.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 22 | $2,860 | $1,306 | 45.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 237 | 385 | $75,075 | $39,268 | 52.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 115 | 115 | $40,250 | $20,960 | 52.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 63 | $8,215 | $3,796 | 46.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 24 | $6,000 | $3,615 | 60.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $5,130 | $2,428 | 47.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 27 | 27 | $4,860 | $2,247 | 46.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $3,740 | $1,877 | 50.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $2,880 | $1,392 | 48.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 239 | 391 | $76,245 | $31,160 | 40.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 122 | 122 | $42,700 | $18,792 | 44.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 50 | $17,000 | $8,754 | 51.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 61 | $8,235 | $3,791 | 46.0% |
About Dr. George Dooneief, MD
Dr. George Dooneief, MD is a Neurology healthcare provider based in Blue Bell, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215976139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Dooneief, MD has received a total of $1,863 in payments from pharmaceutical and medical device companies, with $16.29 received in 2024. These payments were reported across 101 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,343).
As a Medicare-enrolled provider, Dooneief has provided services to 1,826 Medicare beneficiaries, totaling 2,448 services with total Medicare billing of $272,215. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Blue Bell, PA
- Active Since 06/06/2006
- Last Updated 07/06/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1215976139
Products in Payments
- TROKENDI XR (Drug) $124.53
- TYSABRI (Biological) $116.22
- GILENYA (Drug) $82.38
- NAMZARIC (Drug) $77.87
- OXTELLAR XR (Drug) $71.08
- INBRIJA (Drug) $66.35
- AJOVY (Drug) $65.64
- ONFI (Drug) $63.77
- SOLIRIS (Drug) $60.42
- EMGALITY (Drug) $53.08
- MAYZENT (Drug) $45.03
- RYTARY (Drug) $44.03
- VRAYLAR (Drug) $43.58
- Rebif (Biological) $40.28
- AUBAGIO (Drug) $38.94
- GOCOVRI (Drug) $37.41
- Aimovig (Biological) $25.33
- Briviact (Drug) $24.71
- SD809-TD (Drug) $23.94
- JORNAY PM (Drug) $23.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Blue Bell
Vidhu Gupta, Ma, MA
Neurology — Payments: $5,743
Neurology $5,743
Igor Porotov, M.d, M.D
Neurology — Payments: $1,403
Neurology $1,403
Malcolm Mcharg, Md, MD
Neurology — Payments: $1,037
Neurology $1,037
Laurance Smith, Md, MD
Neurology — Payments: $929.73
Neurology $929.73
Lawrence Kerson, Md, MD
Neurology — Payments: $250.00
Neurology $250.00